Financials
- Market Capitalization 653.17 M
- Employee 191
- Founded 2006
- CEO N/A
- Website www.cormedix.com
- Headquarter Delaware, United States
- FIGI BBG000Q4BQK0
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
3.6
ratio cours/chiffre d'affaires
0
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2706 | ALLO Allogene Therapeutics, Inc. - Common Stock | 1.99 USD | -0.50% | -8.29% | +5.85% | +79.28% | 687.53 M USD | ||
| 2726 | MDXG MiMedx Group, Inc - Common Stock | 4.52 USD | -0.44% | +4.39% | +7.36% | -36.25% | 658.84 M USD | ||
| 2735 | SGMT Sagimet Biosciences Inc. - Series A Common Stock | 10.50 USD | +2.34% | +2.34% | +55.79% | +43.44% | 652.67 M USD | ||
| 2741 | PRME Prime Medicine, Inc. - Common Stock | 3.57 USD | -0.56% | -2.46% | +23.53% | +13.69% | 647.52 M USD |